TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/24 18:36 | 8/27/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CEO,P | S | -4 | 1.35 | 0 | -3 | 0 | 1,141 | D | ||||||||||||||
8/6/24 19:56 | 8/2/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CEO,P | S.m | -43 | 1.31 | 0 | -32 | -3 | 1,144 | D | ||||||||||||||
2/5/24 20:40 | 2/2/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | DO | CEO,P | S.m | -108 | 1.42 | 0 | -76 | -6 | 1,176 | D | ||||||||||||||
8/30/23 16:20 | 8/28/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | DO | CEO,P | S.m | -8 | 1.29 | 0 | -6 | -1 | 573 | D | ||||||||||||||
2/3/23 19:41 | 2/2/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CFO | S | -17 | 1.83 | 0 | -10 | -3 | 313 | D | ||||||||||||||
8/30/22 17:00 | 8/29/22 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CFO | S | -5 | 0.8938 | 0 | -6 | -10 | 56 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |